Ultragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Target Price
Analysts' 12-month price predictions for RARE.
Get informed when a big investor buys or sells
+ FollowShare Price
$33.47
Average Target Price
$47.80
42.8% upside
42.8% upside5 analysts in the last 4 months
High: $67 | Low: $26
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Wedbush | $26 |  22.3% downside |  |
| 2026-05-08 | Guggenheim | $43 | 28.5% upside | |
| 2026-04-29 | BarclaysEliana Merle | $43 | 28.5% upside | |
| 2026-04-16 | Morgan Stanley | $67 | 100.2% upside | |
| 2026-03-12 | Leerink PartnersJoseph Schwartz | $60 | 79.3% upside | |
| 2026-02-18 | Evercore ISIGavin Clark-Gartner | $34 | 1.6% upside | |
| 2026-02-17 | Evercore ISI | $37 | 10.5% upside | |
| 2026-02-17 | H.C. WainwrightRaghuram Selvaraju | $50 | 49.4% upside | |
| 2026-02-13 | Goldman Sachs | $61 | 82.3% upside | |
| 2026-02-13 | Robert W. Baird | $40 | 19.5% upside | |
| 2026-01-08 | Morgan StanleyMaxwell Skor | $50 | 49.4% upside | |
| 2026-01-05 | H.C. Wainwright | $60 | 79.3% upside | |
| 2026-01-05 | Guggenheim | $52 | 55.4% upside | |
| 2025-12-30 | Wells FargoBen Burnett | $45 | 34.4% upside | |
| 2025-12-30 | Jefferies | $63 | 88.2% upside | |
| 2025-12-29 | Barclays | $44 | 31.5% upside | |
| 2025-12-29 | Robert W. BairdJoel Beatty | $47 | 40.4% upside | |
| 2025-12-29 | Morgan StanleyJeffrey Hung | $55 | 64.3% upside | |
| 2025-11-24 | BarclaysGena Wang | $50 | 49.4% upside | |
| 2025-03-17 | Piper Sandler | $115 | 243.6% upside | |
| 2025-03-07 | Morgan Stanley | $64 | 91.2% upside | |
| 2024-11-06 | Leerink PartnersJoseph Schwartz | $85 | 154% upside | |
| 2024-11-06 | H.C. WainwrightEd Arce | $95 | 183.8% upside | |
| 2024-06-06 | Goldman SachsSalveen Richter | $67 | 100.2% upside | |
| 2024-05-31 | Stifel NicolausDae Gon Ha | $127 | 279.4% upside | |
| 2024-05-31 | Raymond JamesChristopher Raymond | $135 | 303.3% upside | |
| 2024-05-31 | Robert W. BairdJoel Beatty | $72 | 115.1% upside | |
| 2024-05-31 | Canaccord GenuityWhitney Ijem | $111 | 231.6% upside | |
| 2024-04-15 | Stifel NicolausDae Gon Ha | $124 | 270.5% upside | |
| 2024-04-15 | Raymond JamesChristopher Raymond | $130 | 288.4% upside | |
| 2023-02-03 | Morgan Stanley | $95 | 183.8% upside | |
| 2022-12-30 | H.C. Wainwright | $82 | 145% upside | |
| 2022-07-28 | Piper SandlerChristopher Raymond | $130 | 288.4% upside | |
| 2022-07-01 | Stifel Nicolaus | $142 | 324.3% upside | |
| 2022-05-24 | Goldman Sachs | $101 | 201.8% upside | |
| 2022-05-18 | Piper SandlerChristopher Raymond | $135 | 303.3% upside | |
| 2022-05-06 | Morgan Stanley | $109 | 225.7% upside | |
| 2022-05-06 | Leerink Partners | $115 | 243.6% upside | |
| 2022-01-10 | Cowen & Co.Yaron Werber | $124 | 270.5% upside | |
| 2021-11-03 | CitigroupYigal Nochomovitz | $150 | 348.2% upside | |
| 2021-11-03 | WedbushLaura Chico | $92 | 174.9% upside | |
| 2021-09-27 | Piper SandlerChristopher Raymond | $170 | 407.9% upside | |
| 2021-08-19 | UBSEsther Rajavelu | $73 | 118.1% upside | |
| 2021-08-03 | BarclaysGena Wang | $141 | 321.3% upside | |